Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific (TMO) Earnings Expected to Grow: Should You Buy?
Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results?
Thermo Fisher heads into Q1 earnings with Life Sciences Solutions growth in focus, as bioproduction strength and new innovations may drive results.
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report?
Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Thermo Fisher Stock May Benefit Following Collaboration With PRECISE
TMO teams up with PRECISE on a major proteomics study, expanding its role in large biobank projects and precision medicine initiatives.
TMO Stock May Benefit From New Gibco CTS Portfolio Addition
Thermo Fisher unveils the Gibco CTS Compleo system to automate cell therapy manufacturing, targeting efficiency gains and consistency as demand in the fast-growing market rises.
TMO Stock May Gain From the Rollout of Gibco CHOvantage GS CLD Kit
Thermo Fisher may gain as it unveils its Gibco CHOvantage GS CLD Kit to speed biologics development, cut costs and boost cell culture growth.
Thermo Fisher: A High-Quality Life Science Platform Positioned For Growth
Thermo Fisher shares have declined ~20% YTD, presenting an attractive long-term entry point given its resilient business model and broad platform. TMO's diversified segments, recurring consumables revenue, and strong M&A track record underpin its competitive advantage across the life sciences value chain. Despite cautious FY26 guidance (4–6% revenue growth), TMO's EBITDA margin has normalized, and long-term demand drivers remain robust.
Bamco Inc. NY Lowers Stake in Thermo Fisher Scientific Inc. $TMO
Bamco Inc. NY reduced its position in Thermo Fisher Scientific Inc. (NYSE: TMO) by 19.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,712 shares of the medical research company's stock after selling 6,054 shares during the period. Bamco Inc.
Cinctive Capital Management LP Makes New $3.37 Million Investment in Thermo Fisher Scientific Inc. $TMO
Cinctive Capital Management LP bought a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 6,938 shares of the medical research company's stock, valued at approximately $3,365,000. Other hedge
Thermo Fisher Scientific Inc. $TMO is Broyhill Asset Management LLC’s 10th Largest Position
Broyhill Asset Management LLC lifted its stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 530.0% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 7,024 shares of the medical research company's stock after buying an additional 5,909 shares during
Thermo Fisher Scientific Inc. $TMO Shares Sold by Brown Brothers Harriman & Co.
Brown Brothers Harriman and Co. lessened its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 1.2% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 516,385 shares of the medical research company's stock after selling 6,201 shares during
Glenmede Investment Management LP Sells 29,195 Shares of Thermo Fisher Scientific Inc. $TMO
Glenmede Investment Management LP trimmed its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 25.7% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 84,444 shares of the medical research company's stock after selling 29,195 shares during
